Private Advisor Group LLC lowered its position in Zoetis Inc (NYSE:ZTS) by 41.1% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 16,540 shares of the company’s stock after selling 11,550 shares during the period. Private Advisor Group LLC’s holdings in Zoetis were worth $1,221,000 at the end of the most recent quarter.
Several other institutional investors have also recently modified their holdings of the business. Harel Insurance Investments & Financial Services Ltd. acquired a new position in shares of Zoetis during the 4th quarter worth about $108,000. Steward Partners Investment Advisory LLC acquired a new position in shares of Zoetis during the 3rd quarter worth about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its position in shares of Zoetis by 251.9% during the 3rd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 1,900 shares of the company’s stock worth $121,000 after purchasing an additional 1,360 shares during the last quarter. Shine Investment Advisory Services Inc. raised its position in shares of Zoetis by 86.5% during the 3rd quarter. Shine Investment Advisory Services Inc. now owns 2,242 shares of the company’s stock worth $143,000 after purchasing an additional 1,040 shares during the last quarter. Finally, Arthur M. Cohen & Associates LLC acquired a new position in shares of Zoetis during the 4th quarter worth about $202,000. Institutional investors and hedge funds own 93.72% of the company’s stock.
Several research analysts recently weighed in on ZTS shares. Zacks Investment Research downgraded shares of Zoetis from a “hold” rating to a “sell” rating and set a $83.00 price target for the company. in a research report on Saturday, January 13th. Morgan Stanley upgraded shares of Zoetis from an “equal weight” rating to an “overweight” rating and set a $80.00 price target for the company in a research report on Wednesday, November 29th. Jefferies Group restated a “buy” rating on shares of Zoetis in a research report on Friday, November 10th. Craig Hallum restated a “buy” rating and set a $85.00 price target (up previously from $77.00) on shares of Zoetis in a research report on Tuesday, January 2nd. Finally, BidaskClub upgraded shares of Zoetis from a “hold” rating to a “buy” rating in a research report on Tuesday, November 7th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus price target of $79.83.
Shares of Zoetis Inc (NYSE ZTS) opened at $79.73 on Monday. The company has a market cap of $38,850.00, a PE ratio of 36.57, a price-to-earnings-growth ratio of 1.71 and a beta of 1.07. The company has a quick ratio of 1.95, a current ratio of 2.80 and a debt-to-equity ratio of 2.45. Zoetis Inc has a 1-year low of $52.25 and a 1-year high of $81.40.
Zoetis (NYSE:ZTS) last released its quarterly earnings data on Thursday, February 15th. The company reported $0.69 EPS for the quarter, beating the Zacks’ consensus estimate of $0.66 by $0.03. The company had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.40 billion. Zoetis had a net margin of 16.28% and a return on equity of 65.83%. Zoetis’s quarterly revenue was up 14.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.47 EPS. equities research analysts expect that Zoetis Inc will post 3.02 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 1st. Shareholders of record on Friday, April 20th will be issued a $0.126 dividend. The ex-dividend date of this dividend is Thursday, April 19th. This represents a $0.50 dividend on an annualized basis and a yield of 0.63%. Zoetis’s payout ratio is 22.94%.
TRADEMARK VIOLATION WARNING: This news story was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this news story on another website, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2018/02/19/private-advisor-group-llc-has-1-22-million-holdings-in-zoetis-inc-zts.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.